Organization · Venture Capital
Cure Ventures
Cure Ventures is a Boston-based venture capital firm focused on early-stage investments in life sciences and biotechnology, particularly in curative technologies. The firm emphasizes company formation and genetic validation to support innovative therapeutics.
Overview
What Cure Ventures does
What Cure Ventures is
Cure Ventures is a Boston-based venture capital firm focused on early-stage investments in life sciences and biotechnology, particularly in curative technologies. The firm emphasizes company formation and genetic validation to support innovative therapeutics.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- May 6, 2026
Official channels
Find Cure Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cure Ventures as a funder
Investment thesis
Cure Ventures aims to bring cures to life by funding and collaborating with entrepreneurs developing therapeutics for life-altering diseases, focusing on seed funding, genetic validation, and embedded operational support.
Focus narrative
Cure Ventures invests in de novo company formation, primarily in the life sciences sector. Their investment strategy is based on three tenets: a seed funding model to de-risk scientific endeavors, genetic validation to enhance the probability of success, and the involvement of embedded Cure operators to support day-to-day decision-making alongside founders.
Value beyond capital
Cure Ventures adds value to its portfolio companies through a hands-on approach, providing embedded operators who work alongside founders to drive day-to-day decision-making. This collaborative model enhances the probability of success for scientific endeavors and supports the development of therapeutics.
Focus and fit
- Stages
- Seed · Series A · Series B
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Aevum: Developing therapeutic molecules derived from exercise for treating Parkinson’s and related neurodegenerative disorders. (Stage: Seed) Alessatherapeutics: Focused on local delivery of anti-androgen therapy for prostate diseases. (Stage: Clinical, Phase 1) Cenos: Creating a blood-brain barrier shuttle platform for neurological diseases. (Stage: Seed) Clasp: Innovating precision immuno-oncology with next-generation T cell engagers targeting oncogenic driver mutations. (Stage: Series A) Crosslink: Engineering cancer medicines that assemble conditionally in the tumor microenvironment. (Stage: Seed) Kenaitx: Advancing dopamine neuron replacement therapies for neurological disorders. (Stage: Series A) Kobuk: Developing precision biologics for autoimmune and inflammatory diseases. (Stage: Seed) Permeasis: Utilizing proprietary delivery technology for intracellular biologics. (Stage: Seed) Recuro: Offering a virtual-first care delivery platform for personalized health solutions. (Stage: Growth, Post Series B) Tasca Therapeutics: Focusing on precision oncology through post-translational modification of proteins. (Stage: Series A) Tortugas: Developing therapeutics for neurological diseases with a focus on rapid efficacy identification. (Stage: Seed) Triton Therapeutics: Creating first-in-class medicines for autoimmune and fibrotic diseases. (Stage: Clinical) XenImmune: Developing antibody-enzyme fusions to enhance immune responses against tumors. (Stage: Seed)
Common questions
What to know about Cure Ventures
Upseed classifies Cure Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.